In addition, IFN-γ upregulates expression of class II MHC, which in addition to presenting peptides to CD4+ T cells also is a ligand for the inhibitory receptor LAG-335,36 expressed by tumor antigen-specific CD8+ TILs37. Here, CD8A is linked to neoplasm.